BridgeMD
New treatment option for Osteoarthritis Shoulder
Official title Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery
ClinicalTrials.gov ID: NCT07474896
What this study is testing
What is Ropivacaine 0.2% for Interscalene Block?
Ropivacaine 0.2% for Interscalene Block is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for osteoarthritis shoulder.
Also referred to as interscalene brachial plexus block.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study will compare two regional anesthesia techniques for shoulder surgery and evaluate their effects on diaphragmatic function. The standard regional anesthesia technique for shoulder surgery is the interscalene brachial plexus block (ISB), which provides effective analgesia but is frequently associated with ipsilateral hemidiaphragmatic paresis due to phrenic nerve involvement.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 100
You may be able to join if
- Age ≥ 65 years
- Elective shoulder surgery
- ASA I-III
- Planned use of regional anesthesia
- Signed written informed consent
You likely can't join if
- Allergy to local anesthetics
- Planned continuous catheter technique
- BMI \>40 kg/m²
- Coagulopathy or anticoagulation
- Pre-existing phrenic nerve palsy
- Neurological disorder of the operative limb
See the full eligibility criteria
- Age ≥ 65 years
- Elective shoulder surgery
- ASA I-III
- Planned use of regional anesthesia
- Signed written informed consent
- Allergy to local anesthetics
- Planned continuous catheter technique
- BMI \>40 kg/m²
- Coagulopathy or anticoagulation
- Pre-existing phrenic nerve palsy
- Neurological disorder of the operative limb
- Pregnancy or breastfeeding
- Participation in another clinical trial within 30 days
The study team makes the final eligibility decision.
Where it's taking place
- Poznan, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poznan, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.